99 related articles for article (PubMed ID: 17536105)
41. Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21.
Hoebers FJ; Janssen HL; Olmos AV; Sprong D; Nunn AD; Balm AJ; Hoefnagel CA; Begg AC; Haustermans KM
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1206-11. PubMed ID: 12192567
[TBL] [Abstract][Full Text] [Related]
42. Fluosol-DA in radiation therapy.
Lustig RA; McIntosh NL
Prog Clin Biol Res; 1986; 211():29-38. PubMed ID: 3960931
[No Abstract] [Full Text] [Related]
43. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.
Lehtiö K; Eskola O; Viljanen T; Oikonen V; Grönroos T; Sillanmäki L; Grénman R; Minn H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):971-82. PubMed ID: 15234030
[TBL] [Abstract][Full Text] [Related]
44. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
Eschmann SM; Paulsen F; Reimold M; Dittmann H; Welz S; Reischl G; Machulla HJ; Bares R
J Nucl Med; 2005 Feb; 46(2):253-60. PubMed ID: 15695784
[TBL] [Abstract][Full Text] [Related]
45. Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole.
Begg AC; Sheldon PW; Foster JL
Br J Radiol; 1974 Jul; 47(559):399-404. PubMed ID: 4851295
[No Abstract] [Full Text] [Related]
46. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
47. Lonidamine and radiotherapy in head and neck cancers. A pilot study.
Magno L; Terraneo F; Ciottoli GB
Oncology; 1984; 41 Suppl 1():113-5. PubMed ID: 6717889
[TBL] [Abstract][Full Text] [Related]
48. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
[TBL] [Abstract][Full Text] [Related]
49. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
Busk M; Horsman MR; Jakobsen S; Keiding S; van der Kogel AJ; Bussink J; Overgaard J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1202-12. PubMed ID: 18313528
[TBL] [Abstract][Full Text] [Related]
50. [Clinical application of PET and PET/CT in radiotherapy of head and neck cancer].
Chen B; Gao L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):425-30. PubMed ID: 16900650
[TBL] [Abstract][Full Text] [Related]
51. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
Kogelnik HD
Wien Klin Wochenschr; 1983 Aug; 95(15):515-8. PubMed ID: 6636784
[TBL] [Abstract][Full Text] [Related]
52. Effect of radiation-sensitizing agents in radiation therapy of mouse mammary carcinoma.
Suit HD; Hewitt R; Urano M
Radiology; 1970 Jan; 94(1):189-95. PubMed ID: 5410341
[No Abstract] [Full Text] [Related]
53. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
Li XP; Liang Y; Liu X; Wang QS; Wu HB
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869
[TBL] [Abstract][Full Text] [Related]
54. Radiobiologic research for head and neck cancer therapy. Therapeutic implications.
Weichselbaum RR; Rose CM; Ervin TJ; Miller D
Arch Otolaryngol; 1983 Dec; 109(12):792-6. PubMed ID: 6357165
[TBL] [Abstract][Full Text] [Related]
55. Clinical science and patient care: lessons from cooperative randomized clinical trials.
Cox JD
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):273-4. PubMed ID: 9308927
[No Abstract] [Full Text] [Related]
56. Combination therapy involving photosensitizing agents.
Kessel D
J Photochem Photobiol B; 1992 Jan; 12(2):203-4. PubMed ID: 1619518
[No Abstract] [Full Text] [Related]
57. Tumor line dependent interactions of irradiation and cis-diamminedichloroplatinum in the multicellular tumor spheroid system.
Yuhas JM; Tarleton AE; Culo F
Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1373-5. PubMed ID: 575123
[No Abstract] [Full Text] [Related]
58. "Reports of my death [may be] greatly exaggerated" (adapted from Mark Twain)--in response to Dr. J. M. Brown, IJROBP 32:883-885; 1995.
Coleman CN
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1264-5. PubMed ID: 7662001
[No Abstract] [Full Text] [Related]
59. Manipulation and exploitation of the tumour environment for therapeutic benefit.
Stratford IJ; Adams GE; Bremner JC; Cole S; Edwards HS; Robertson N; Wood PJ
Int J Radiat Biol; 1994 Jan; 65(1):85-94. PubMed ID: 7905915
[TBL] [Abstract][Full Text] [Related]
60. Hypoxia revisited.
Hall EJ
J Natl Cancer Inst; 1991 Feb; 83(3):156. PubMed ID: 1988697
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
